PLAUR and colorectal carcinoma: No serological marker has yet been accepted for use in early detection of CRC (Duffy et al, 2007), even though some serological biomarkers, among these the urokinase receptor, uPAR, have proven to be strong prognostic markers in CRC (Stephens et al, 1999).